A Houston company that’s changing the game when it comes to early bleed detection has raised its next round of funding.
Saranas Inc. announced that it closed a $12.8 million series B investment led by Wisconsin-based Baird Capital, the venture capital and global private equity arm of Baird, a global company with a location in Houston. Austin-based S3 Ventures also supported the round.
The company will use the funds to continue its clinical trials, per a news release.